Foreground Capital
Venture capitalActively deployingSan Francisco · Seed–Series B · 5 people tracked
Investment thesis
Foreground Capital invests in companies addressing health conditions that affect women directly, differently, and disproportionately. Operating within a trillion-dollar market opportunity, the firm is guided by four core impact pillars—Transformative Innovation, Access, Affordability, and Systemic Change—to deliver both meaningful healthcare improvements for women and competitive financial returns. The firm believes women's health innovation serves as a blueprint for the future of healthcare.
Source: firm website, verified Jul 21, 2026.
Team · 5 people
from the firm's websiteElizabeth Bailey is a co-founder and managing partner at Foreground Capital with over 20 years of venture capital and early-stage healthcare company experience. She previously co-founded and led RH Capital's women's health portfolio and was a partner at Commons Capital managing healthcare investments including several successful exits.
Stasia Obremskey is a co-founder and managing partner at Foreground Capital with a career focused on women's health investment. She previously co-founded and led RH Capital's women's health venture portfolio. Before venture capital, she worked as a CFO for healthcare organizations in the US and Asia, and began her career in management consulting at Bain & Company and investment banking at Morgan Stanley.
Alice Zheng is a partner at Foreground Capital with a background spanning global health, clinical medicine, and management consulting at McKinsey & Company. She holds an MD/MPH and MBA from Harvard Business School, and has served as a principal at RH Capital where she contributed to building one of the largest dedicated women's health venture portfolios.
Molly Ward is the Chief of Staff at Foreground Capital, bringing expertise in healthcare operations, partnerships, and strategy. She began her career in global health at Massachusetts General Hospital working across India, Uganda, and the US, and has held roles in operations and strategy at health and wellness startups, tech companies, and insurance firms.
Yvanka de Soysa is a biomedical scientist and associate at Foreground Capital with expertise in translational science and venture capital. She holds a PhD in cardiac development and single-cell genomics from UCSF and previously worked at Hevolution Foundation investing in early-stage aging therapeutics, at venture capital firm 5AM Ventures, and in venture creation at Flagship Pioneering.
What they invest in
from 10 of 45 portfolio companiesFemTech ×8Healthtech ×8Digital Health ×6Wellness & Fitness ×3AI & Machine Learning ×2Biotech ×2Consumer ×2Medical Devices ×2
HQs:United States×4Canada×1
Investments · 45 tracked
founders shown can be your intro pathNext-gen treatment for urinary incontinence.
AOA Dx develops a blood-based liquid biopsy platform using mass spectrometry and machine learning to detect ovarian cancer at early stages through tumor-associated biomarkers in serum. The company serves oncologists and patients in women's health diagnostics.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesDenver, US
Oriana(CEO)AlexAnna(Chief Regulatory Officer)<UNKNOWN>
Medical device company dedicated to improving pregnancy outcomes and reducing the risk of preterm birth.
Cadence provides over-the-counter contraceptive products including morning-after pills, pregnancy tests, and UTI relief kits distributed through convenience stores. The company focuses on improving access to affordable reproductive health products without prescription or insurance requirements.
ConsumerFemTechHealthtech
Providing insurance-covered specialized therapy and community support for perinatal mental health conditions.
Mobilizing the power of the community and technology to deliver personalized, home-based maternity care for underserved communities.
Making continuous hormone monitoring possible by bringing the first at-home technology, giving real time insights from the hormones in your saliva.
Cofertility connects intended parents seeking egg donors with women who want to freeze their eggs for their own future, offering a "Split" program where women can donate eggs while subsidizing their own egg-freezing costs.
FemTechHealthtechNew York, US
Launching a new era of contraception through human-centered design and harnessing the natural barrier properties of cervical mucus.
Eli develops and manufactures at-home hormone level tests that collect longitudinal data on daily hormonal patterns. The company serves individuals interested in tracking their hormone levels through accessible, simple testing.
ConsumerDeep TechDigital HealthFemTechWellness & FitnessMontréal, CA
Delivering at-home vaginal microbiome tests designed to close the gender health gap and improve female health.
Evvy is an AI-powered precision medicine platform using vaginal microbiome testing and analysis to diagnose and treat women's health conditions including vaginal health, fertility, and menopause. The platform translates vaginal microbiome data into personalized care pathways and novel biomarker discovery for women who have historically been excluded from clinical research.
AI & Machine LearningDigital HealthFemTechHealthtech
PriyankaPita
Developing a non-hormonal treatment for endometriosis to reduce pain and lesion burden.
Bringing equity to sexual and reproductive health by increasing access, convenience and affordability through telehealth and online pharmacy.
Revolutionizing maternal health through data-driven solutions and remote prenatal care.
Neuspera develops an integrated sacral neuromodulation system for treating urinary urge incontinence, using a smart implanted neurostimulator paired with a wireless external battery. The device is designed for women with overactive bladder symptoms.
HealthtechMedical Devices
Ovia Health provides digital health tools and clinical programs for reproductive and family health, including fertility, pregnancy, and parenthood support. The platform delivers personalized coaching, health pathways, and risk identification to help families across their health journey.
Digital HealthFemTechHealthtechWellness & FitnessBoston, US
Building the family planning company of the 21st century with novel non-hormonal contraceptives for men and women.
Seven Starling provides virtual mental healthcare and psychiatric support for women experiencing anxiety, depression, or trauma related to fertility, pregnancy, pregnancy loss, postpartum, early parenthood, and menopause. The service matches patients with therapists and psychiatric nurse practitioners, accepts most commercial insurance and Medicaid, and operates across 20+ U.S. states.
Digital HealthFemTechMental Health
Pioneering the next class of glycolipid biomarkers revolutionary for the early detection and diagnosis of ovarian cancer.
Providing results, at home, in minutes through tech-enabled sexually-transmitted infection (STI) self-testing kits.
Providing telehealth and online pharmacy services with reproductive and sexual health brand.
Transforming episodic care into continuous support across fertility, maternity and parenting with a digital health platform.
Redesigning maternity care with holistic, tech-enabled, midwife-led pregnancy care.
Inventing the future of male contraception with the first long-lasting, reversible implant solution for men.
YourChoice Therapeutics is developing YCT-529, a non-hormonal oral contraceptive for men currently in Phase 2 clinical trials. The company targets male contraceptive users seeking alternatives to condoms or vasectomy.
BiotechFemTechHealthtech
Akash Bakshi, MSc(Co-founder & CEO)Nadja Mannowetz, PhD(Co-founder & CSO)
Frequently asked questions
- What stage does Foreground Capital invest at?
- Foreground Capital invests at the Seed, Series A, Series B stages.
- What sectors does Foreground Capital focus on?
- Foreground Capital focuses on Biotech, Digital Health, FemTech, Healthtech, Medical Devices.
- Where is Foreground Capital located?
- Foreground Capital is headquartered in San Francisco, US.
- Does Foreground Capital lead rounds?
- Yes, Foreground Capital leads investment rounds.
Similar investors
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
Breyer Capital is a venture capital firm that invests in high-impact entrepreneurs with a strategic focus on companies leveraging artificial intelligence and machine learning to transform technology sectors globally.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
GV is Alphabet's venture capital arm, established in 2009 as Google Ventures. Operating with long time horizons and over $13 billion in assets under management, the firm invests across technology and life sciences sectors from seed to growth stages, supporting 400 active portfolio companies across North America, Europe, and Israel.
Innovestor is a Finnish investment manager that operates across venture capital, real estate, and energy storage sectors. The firm invests in early-stage technology and life science startups, energy-efficient commercial real estate, and battery storage and solar solutions. Innovestor also provides corporate venturing advisory services.